View of TREATMENT OUTCOMES OF FIRST-LINE OSIMERTINIB IN ELDERLY PATIENTS WITH ADVANCED EGFR-MUTANT NON-SMALL CELL LUNG CANCER

Return to Article Details TREATMENT OUTCOMES OF FIRST-LINE OSIMERTINIB IN ELDERLY PATIENTS WITH ADVANCED EGFR-MUTANT NON-SMALL CELL LUNG CANCER Download Download PDF